RU2003107692A - PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND BENZAMIDE - Google Patents

PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND BENZAMIDE

Info

Publication number
RU2003107692A
RU2003107692A RU2003107692/15A RU2003107692A RU2003107692A RU 2003107692 A RU2003107692 A RU 2003107692A RU 2003107692/15 A RU2003107692/15 A RU 2003107692/15A RU 2003107692 A RU2003107692 A RU 2003107692A RU 2003107692 A RU2003107692 A RU 2003107692A
Authority
RU
Russia
Prior art keywords
benzamide
pharmaceutical composition
ondansetron
composition containing
containing ondansetron
Prior art date
Application number
RU2003107692/15A
Other languages
Russian (ru)
Other versions
RU2228752C1 (en
Inventor
Леонид Андреевич Ильин
Кирилл Семенович Мартиросов
Валерий Владимирович Зорин
Ирина Ефимовна Андрианова
Original Assignee
Государственный научный центр-Институт биофизики
Filing date
Publication date
Application filed by Государственный научный центр-Институт биофизики filed Critical Государственный научный центр-Институт биофизики
Priority to RU2003107692/15A priority Critical patent/RU2228752C1/en
Priority claimed from RU2003107692/15A external-priority patent/RU2228752C1/en
Application granted granted Critical
Publication of RU2228752C1 publication Critical patent/RU2228752C1/en
Publication of RU2003107692A publication Critical patent/RU2003107692A/en

Links

Claims (2)

1. Обладающая противорвотной активностью фармацевтическая композиция, содержащая ондансетрон, отличающаяся тем, что в качестве второго фармакологически активного агента используют бензамид, причем ондансетрон и бензамид применяют в массовом соотношении от 1:4 до 1:200.1. Having an antiemetic activity, a pharmaceutical composition containing ondansetron, characterized in that benzamide is used as the second pharmacologically active agent, wherein ondansetron and benzamide are used in a weight ratio of from 1: 4 to 1: 200. 2. Фармацевтическая композиция, предотвращающая токсическое действие цитостатиков и других лекарственных средств, используемых при лечении раковых больных, содержащая ондансетрон, отличающаяся тем, что в качестве второго фармакологически активного агента используют бензамид или его производные, причем ондансетрон и бензамид или его производные применяют в массовом соотношении от 1:5 до 1:50.2. A pharmaceutical composition that prevents the toxic effects of cytostatics and other drugs used in the treatment of cancer patients, containing ondansetron, characterized in that benzamide or its derivatives are used as the second pharmacologically active agent, and ondansetron and benzamide or its derivatives are used in a mass ratio from 1: 5 to 1:50.
RU2003107692/15A 2003-03-21 2003-03-21 Pharmaceutical composition containing ondansetron and benzamide RU2228752C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2003107692/15A RU2228752C1 (en) 2003-03-21 2003-03-21 Pharmaceutical composition containing ondansetron and benzamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2003107692/15A RU2228752C1 (en) 2003-03-21 2003-03-21 Pharmaceutical composition containing ondansetron and benzamide

Publications (2)

Publication Number Publication Date
RU2228752C1 RU2228752C1 (en) 2004-05-20
RU2003107692A true RU2003107692A (en) 2004-09-20

Family

ID=32679544

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2003107692/15A RU2228752C1 (en) 2003-03-21 2003-03-21 Pharmaceutical composition containing ondansetron and benzamide

Country Status (1)

Country Link
RU (1) RU2228752C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2509557C1 (en) * 2012-06-28 2014-03-20 Федеральное государственное унитарное предприятие Научно-производственный центр "Фармзащита" Федерального медико-биологического агентства Pharmaceutical composition for reduction of primary radiation response and early transient incapability

Similar Documents

Publication Publication Date Title
RU2325389C2 (en) Composition and derivatives of substituted azaindoloxoacetapiperazine characterized by antiviral activity
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
WO2005065646A3 (en) Novel drug compositions and dosage forms
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
ATE452129T1 (en) N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES
NO20065904L (en) Therapeutic compounds
TW200633978A (en) 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists
ATE543491T1 (en) COMBINATION PREPARATION CONTAINING IBUPROFEN AND PARACETAMOL
SE9901573D0 (en) New compounds
DE50203456D1 (en) DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICAMENTS CONTAINING SUCH COMPOUNDS
SE0102440D0 (en) New compound
WO2005065648A3 (en) Novel drug compositions and dosage forms of topiramate
BE2016C017I2 (en)
TR200103144T2 (en) New compounds
RU2003107692A (en) PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND BENZAMIDE
RU2006145311A (en) SOLID PHARMACEUTICAL COMPOSITION
SE0000303D0 (en) Novel compounds
AR022338A1 (en) A BENZAMIDE COMPOUND, A MEDICINAL PRODUCT CONTAINING IT, AND USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OR PREVENTION OF A DIGESTIVE DISEASE OR TO IMPROVE THE MOBILITY OF THE GASTROINTESTINAL TRACT.
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
MXPA04005033A (en) Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes.
EA200701525A1 (en) PHARMACEUTICAL POLYMERIC COMPOSITION FOR ORAL ADMINISTRATION OF TERBUTALINE SULFATE WITH CONTROLLED DELIVERY
JP2006503049A5 (en)
RU2003119194A (en) PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON, METACIN AND BENZAMIDE
ATE298564T1 (en) MEDICINAL FORMULATION CONTAINING AN LTB4 ANTAGONIST AND A MOETUFACTURING AGENT
DE60327249D1 (en) ANTHRANILIC ACID AMIDE AND ITS PHARMACEUTICAL USE